CGNSF - Cognetivity Neurosciences Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD

Cognetivity Neurosciences Ltd.

1055 West Hastings Street
Suite 2250
Vancouver, BC V6E 2E9

IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Sina HabibiCo-Founder, CEO & DirectorN/AN/AN/A
Dr. Seyed-Mahdi Khaligh-RazaviCo-Founder & Chief Scientific OfficerN/AN/AN/A
Ms. Denise Lok C.P.A., CA, CPA, ACISCFO & Corp. Sec.N/AN/A1984
Dr. Thomas Roger SawyerChief Operating OfficerN/AN/A1970
Dr. Mark A. PhillipsChief Compliance Officer & DirectorN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops integrated cognitive assessment, a cognitive testing platform, which includes visual stimulus based diagnostic test and artificial intelligence tools to support the early detection and monitoring of cognitive impairment in neurodegenerative diseases, such as Alzheimer's and dementia. The company is headquartered in Vancouver, Canada.

Corporate Governance

Cognetivity Neurosciences Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.